Search for: "In Re: Engle Cases" Results 81 - 100 of 117
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Mar 2021, 4:17 pm by Law Lady
., Appellee. 3rd District.Civil procedure -- Summary judgment -- Affidavit in opposition to motion -- Declaration -- Where declarations submitted in opposition to summary judgment were based upon personal knowledge and sworn under penalty of perjury, and motion to exclude these documents was not made until summary judgment hearing, trial court erred in denying movant's motion for continuance to correct technical differences between a declaration and an affidavit in opposition -- Whether… [read post]
20 Aug 2009, 3:01 am
General Assembly in Resolution A/RES/34/180 on December 18, 1979. [read post]
11 Nov 2022, 2:46 pm by admin
The lawsuit industry, however, armed with an FDA warning, pressed its cases. [read post]
12 Nov 2012, 4:14 pm by Schachtman
Mills and Duane Alexander, “Teratogens and ‘Litogens’,” 15 New Engl. [read post]
5 Jul 2015, 9:42 am by Schachtman
Liang, “Silicone Breast Implants and the Risk of Connective-Tissue Diseases and Symptoms,” 332 New Engl. [read post]
23 Dec 2023, 7:16 pm by admin
Animal model studies can be both reliable and relevant in toxic tort cases. [read post]
12 Jun 2023, 1:09 pm by admin
It is long past time to stop citing the case. [read post]
3 Dec 2011, 9:56 am by Law Lady
Lauderdale Division.Civil procedure -- Default -- Vacation -- Excusable neglect -- In action for breach of contract, open account and unjust enrichment in which default had been entered for defendants' failure to file answer to original complaint, where trial court first granted defendants' motion for vacation of default judgment on grounds of lack of subject matter jurisdiction based on forum selection clause, then upon plantiff's motion for rehearing determined it did have… [read post]
13 Apr 2024, 3:33 pm by admin
The Yale HSP authors delivered their final report on their case-control study to FDA, in May 2020.[6] The HSP was a study, with 702 HS cases, and over 1,376 controls, men and women, ages 18 to 49. [read post]
1 Jan 2013, 1:27 pm by Larry Catá Backer
Part III then considers two case studies as a means of structuring discussion; the first from India involving two large multinational enterprises and the rights based approach; the second from China involving the development of complex administrative and rules based private CSR codes of conduct. [read post]
11 Aug 2011, 1:09 pm by Bexis
Ct. 2567 (2011), has knocked out warning claims in generic drug cases. [read post]